Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Patients with alopecia areata face treatment barriers due to lack of reimbursement and need more support and information.

Dang Gui may help treat immune-related diseases by boosting and regulating the immune system.

Type I interferons may help treat skin issues in lupus and dermatomyositis.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

COVID-19 can increase the risk of hair loss, especially in people over 40.

Chronic autoimmune urticaria can be managed with specific therapies and requires improved diagnosis and treatment methods.

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.

Improved CRBN ligands make protein degraders more effective and drug-like.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

lncRNAs are important for understanding and treating skin diseases.

Blocking Prostaglandin D₂ may help treat hair loss.

COVID-19 can cause hair loss, but specialists can help treat it.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

Double-stranded RNA activates a pathway that causes a skin protein to be expressed in the wrong place.

Blocking Prostaglandin D₂ (PGD₂) could help treat hair loss.

Gypenosides from Gynostemma pentaphyllum were found to have anti-aging effects, increasing skin collagen and reducing wrinkles.

Lithocholic acid helps hair growth and regeneration in alopecia by activating vitamin D receptors.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Ruxolitinib treatment may cause eyelash growth.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.